Profile of Tumor Necrosis Factor Alpha Levels in Childhood Malignancy with Febrile Neutropenia
DOI:
https://doi.org/10.24293/ijcpml.v28i3.1886Keywords:
TNF-α, positive blood cultures, negative blood culturesAbstract
Infection is a significant cause of morbidity and mortality in childhood malignancy with Febrile Neutropenia (FN). Tumor Necrosis Factor-Alpha (TNF-α) is involved in host defense against bacterial invasion. However, changes in TNF-α levels with the possibility of bacterial infection confirmed by blood culture are still unclear. The study aimed to evaluate TNF-α levels in childhood malignancy with FN who had blood cultures with a control group. Observational cross-sectional analysis during January-October 2020 at Dr. Soetomo General Academic Hospital, Surabaya. Childhood malignancy with FN episodes as the case group and nonfebrile neutropenia as the control. TNF-α levels examination used plasma with the Enzyme-Linked Immunosorbent Assay (ELISA) sandwich method. Blood culture results were obtained from the patient's medical record. The differences in TNF-α levels in the case groups and control were analyzed by the T-square test for two independent samples or Mann-Whitney U according to the data distribution. There were 18 cases group with 30 FN episodes and 15 controls. There were 8(26.66%) positive and 22(73.33%) negative blood cultures from 30 FN episodes. The mean TNF-α levels in the positive blood culture cases group and control: 14.72±5.77 and 9.78±2.74 pg/mL, and the median (min-max) negative blood cultures: 12.19 (7.01-25.70) pg/mL. There was no significant difference in TNF-α levels in the positive and negative blood culture cases group (p=0.527), but there was a significant difference in the control (p=0.049 and p=0.027). Therefore, TNF-α levels cannot be used as a marker of bacterial infection in the case groups.Downloads
References
Baraka A, Zakaria M. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies. Int J Hematol, 2018; 108(2): 184-91.
Liu KT, Liu YH, Lin CY, Kuo PL, Yen MC. Inflammatory molecules expression pattern for identifying
pathogen species in febrile patient serum. Exp Ther Med, 2016; 12(1): 312-8.
Xia T, Xu X, Zhao N, Luo Z, Tang Y. Comparison of the diagnostic power of cytokine patterns and
procalcitonin for predicting infection among pediatric hematology/oncology patients. Clin Microbiol Infect, 2016; 22(12): 996-1001.
Araujo OR de, Salomí£o R, Brunialti MKC, Silva DCB da, Senerchia AA, et al. Cytokine kinetics in febrile
neutropenic children: Insights on the usefulness as sepsis biomarkers, influence of filgrastim, and
behavior of the IL-23/IL-17 pathway. Mediators Inflamm, 2017; 2017(1): 1-10.
Siegmund M, Pagel J, Scholz T, Rupp J, Härtel C, Lauten M. Proinflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy. Mol Cell Pediatr, 2020;
(1): 5.
Dien Bard J, McElvania Tekippe E. Diagnosis of bloodstream infections in children. Kraft CS, editor. J
Clin Microbiol, 2016; 54(6): 1418-24.
Klastersky J, de Maurois J, Rolston K, Rapoport B, Maschmeyer G, et al. Management of febrile
neutropenia: ESMO clinical practice guidelines. Ann Oncol, 2016; 27(suppl_5): v111-8.
Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol
Pract, 2019; 15(1): 19-24.
Zermatten MG, Koenig C, von Allmen A, Agyeman P, Ammann RA. Episodes of fever in neutropenia in
pediatric patients with cancer in Bern, Switzerland, 1993-2012. Sci Data, 2019; 6(1): 180304.
Malabagi A, Shetty R, Sinha M, Jayashree R, Govindbabu, Lakshmaiah K. Febrile neutropenia in
hematological malignancies: Clinical and microbiological profile and outcome in high-risk patients. J Lab Physicians, 2015; 7(2): 116-20.
Elabscience. Human TNF-α (Tumor Necrosis Alpha) ELISA kit. USA: Elabscience, 2019; 1-11.
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, et al. International incidence of childhood cancer, 2001-10: A population-based registry study. Lancet Oncol, 2017; 18(6): 719-31.
Cureresearch.org. Number of childhood cancer diagnosed per year [Internet]. Cure research for
children's cancer. 2019; 1. Available from: cureresearch.org/Number-of-Diagnoses (accessed
September 24, 2020).
Chen L, Deng H, Cui H, Fang J, Zuo Z, et al. Inflammatory responses and inflammation-associated
diseases in organs. Oncotarget, 2018; 9(6): 7204-18.
van der Galií«n HT, Loeffen EAH, Miedema KGE, Tissing WJE. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia. Support Care Cancer, 2018; 26(11):
-26.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol, 2018; 9(754): 1-8.
Arokiasamy S, Zakian C, Dilliway J, Wang W, Nourshargh S, Voisin MB. Endogenous TNF-α orchestrates the trafficking of neutrophils into and within lymphatic vessels during acute inflammation. Sci Rep, 2017; 7(1): 44189.
Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: Biological roles and clinical
therapeutic applications. J Hematol Oncol, 2019; 12(1): 76.
Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology, 2019; 8(7): 1-10.
Monastero RN, Pentyala S. Cytokines as Biomarkers and their respective clinical cut-off levels. Int J Inflam, 2017; 2017: 1-11.
Rukmono P, Dharmasetiawani N, Warsono, Wirasti Y. Tumor necrosis factor-alpha and interleukin-6 in early-onset neonatal sepsis. Paediatr Indones, 2016; 56(1): 15-7.
Rezende Caino de Oliveira F, Araujo OR, Cardoso Bourguignon da Silva D, Genaro Arduini R, Petrilli AS, Salomí£o R. Abstract P-288. Pediatr Crit Care Med, 2018; 19(1): 134.
Silva LB, dos Santos Neto AP, Maia SMAS, dos Santos Guimarí£es C, Quidute IL, et al. The role of TNF-α as a proinflammatory cytokine in pathological processes. Open Dent J, 2019; 13(1): 332-8.
Chae BS. Pretreatment of low-dose and super-low-dose LPS on the production of in-vitro LPS-induced inflammatory mediators. Toxicol Res, 2018; 34(1): 65-73.
Tawfig N. Proinflammatory cytokines and periodontal disease. J Dent Probl Solut, 2016; 1(1): 012-7.
Chuang TY, Cheng AJ, Chen IT, Lan TY, Huang IH, et al. Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone. Oncotarget, 2017; 8(30): 49735-48.
Zafar Iqbal-Mirza S, Serrano Romero de ívila V, Estévez-González R, Rodríguez-González D,
Heredero-Gálvez E, Julián-Jiménez A. Ability of procalcitonin to differentiate true bacteraemia from
contaminated blood cultures in an emergency department. Enfermedades Infecc y Microbiol Clin
(English ed). 2019; 37(9): 560-8.
Garraud O, Tariket S, Suite C, Haddad A, Aloui C, et al. Transfusion as an inflammation hit: Knowns and unknowns. Front Immunol, 2016; 7(534): 1-10.
Neemann K, Yonts AB, Qiu F, Simonsen K, Lowas S, Freifeld A. Blood cultures for persistent fever in
neutropenic pediatric patients are of low diagnostic yield. J Pediatric Infect Dis Soc, 2016; 5(2): 218-21.
T, Sobo ska J, Salamon D, McFarlane IM, Zi tkiewicz M, Gosiewski T. Classical microbiological diagnostics of bacteremia: Are the negative results really negative? What is the laboratory result telling us about the "Gold Standard"?. Microorganisms, 2020; 8(3): 346.
Opota O, Croxatto A, Prod'hom G, Greub G. Blood culture-based diagnosis of bacteremia: State of the art. Clin Microbiol Infect, 2015; 21(4): 313-22.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
